NAPLES, Florida — In this video, Jana G. Al Hashash, MD, MS, discusses her presentation on malignancies in IBD from the 2022 ACG/FGS Annual Spring Symposium.
“Patients with [IBD] are at increased risk of certain malignancies due to their underlying condition or the medications that we use to treat this condition,” Al Hashash, a gastroenterologist and faculty member at the Mayo Clinic in Jacksonville, told Healio.